00000000|MMI|125.82|Postoperative Period|C0032790|[tmco]|["Postoperative"-tx-27-"postoperative"-noun-0,"Postoperative"-tx-24-"postoperative"-adj-0,"Postoperative"-tx-20-"postoperative"-noun-0,"Postoperative"-tx-19-"postoperative"-noun-0,"Postoperative"-tx-17-"postoperative"-noun-0,"Postoperative"-tx-16-"postoperative"-noun-0,"Postoperative"-tx-12-"postoperative"-noun-0]|TX|2752/13;2524/13;1741/13;1634/13;1490/13;1410/13;1205/13|E04.614.750;N02.421.585.753.750
00000000|MMI|67.44|Togo|C0040363|[geoa]|["TO"-tx-30-"to"-adv-0,"TO"-tx-28-"to"-adv-0,"TO"-tx-20-"to"-adv-0]|TX|[3128/2],[3143/2];2871/2;1729/2|Z01.058.290.190.800
00000000|MMI|67.44|Tryptophanase|C0041260|[aapp,enzy]|["TO"-tx-30-"to"-adv-0,"TO"-tx-28-"to"-adv-0,"TO"-tx-20-"to"-adv-0]|TX|[3128/2],[3143/2];2871/2;1729/2|D08.811.520.224.800
00000000|MMI|58.00|Obesity, Morbid|C0028756|[dsyn]|["Morbid Obesity"-tx-21-"morbid obesity"-noun-0,"Morbid Obesity"-tx-2-"Morbid obesity"-noun-0]|TX|1999/14;292/14|C18.654.726.500.700;C23.888.144.699.500.500;E01.370.600.115.100.160.120.699.500.500;G07.100.100.160.120.699.500.500
00000000|MMI|49.39|Pain|C0030193|[sosy]|["PAIN"-tx-24-"pain"-noun-0,"PAIN"-tx-23-"pain"-noun-0,"PAIN"-tx-20-"pain"-noun-0]|TX|2202/4;2162/4;1847/4|C10.597.617;C23.888.592.612;F02.830.816.444;G11.561.600.810.444
00000000|MMI|49.28|Coronary Artery Disease|C1956346|[dsyn]|["Coronary Disease"-tx-5-"coronary disease"-noun-0,"Coronary Disease"-tx-3-"coronary disease"-noun-0,"CORONARY ARTERY DISEASE"-tx-2-"coronary artery disease"-noun-0]|TX|609/16;441/16;309/23|C14.280.647.250.260;C14.907.137.126.339;C14.907.585.250.260
00000000|MMI|40.32|Staple, Surgical|C0524724|[medd]|["staples"-tx-29-"staples"-noun-0,"Staple"-tx-28-"staple"-noun-0,"staples"-tx-27-"staples"-noun-0]|TX|2965/7;2808/6;2723/7|E07.858.690.820
00000000|MMI|39.87|Rehabilitation therapy|C0034991|[topp]|["Rehab"-tx-28-"rehab"-noun-0,"Rehabilitation"-tx-21-"Rehabilitation"-noun-0,"Rehab"-tx-20-"rehab"-noun-0]|TX|2865/5;1889/14;1732/5|E02.831;H02.403.680.600;N02.421.784
00000000|MMI|39.67|Coronary heart disease|C0010068|[dsyn]|["CORONARY DISEASE"-tx-5-"coronary disease"-noun-0,"CORONARY DISEASE"-tx-3-"coronary disease"-noun-0,"Coronary (artery) disease"-tx-2-"coronary artery disease"-noun-0]|TX|609/16;441/16;309/23|C14.280.647.250;C14.907.585.250
00000000|MMI|39.21|Patient Discharge|C0030685|[hlca]|["Discharged"-tx-30-"discharged"-verb-0,"Discharged"-tx-20-"discharged"-verb-0]|TX|3081/10;1718/10|E02.204.125;E02.760.400.610;N02.421.192.125;N02.421.585.400.610;N04.590.233.727.210.125
00000000|MMI|38.80|Lovenox|C0728963|[orch,phsu]|["Lovenox"-tx-30-"Lovenox"-noun-0,"Lovenox"-tx-24-"Lovenox"-noun-0]|TX|3025/7;2546/7|D09.698.373.400.300.200
00000000|MMI|35.81|Cardiac Catheterization Procedures|C0018795|[hlca]|["Cardiac catheterisation"-tx-8-"cardiac catheterization"-noun-0,"Cardiac catheterisation"-tx-5-"cardiac catheterization"-noun-0]|TX|928/23;633/23|E01.370.370.380.140;E02.148.442;E05.157.250
00000000|MMI|32.66|Lipitor|C0593906|[orch,phsu]|["Lipitor"-tx-24-"Lipitor"-noun-0,"Lipitor"-tx-9-"Lipitor"-noun-0]|TX|2317/7;1004/7|D03.383.129.578.075;D10.251.450.200
00000000|MMI|32.66|Zyrtec|C0162723|[orch,phsu]|["ZyrTEC"-tx-24-"Zyrtec"-noun-0,"ZyrTEC"-tx-9-"Zyrtec"-noun-0]|TX|2373/6;1014/6|D03.383.606.515.200
00000000|MMI|30.42|Aspirin|C0004057|[orch,phsu]|["ASPIRIN"-tx-9-"aspirin"-noun-0]|TX|1039/7|D02.455.426.559.389.657.410.595.176
00000000|MMI|28.65|Obesity|C0028754|[dsyn]|["OBESE"-tx-3-"obese"-adj-0]|TX|423/5|C18.654.726.500;C23.888.144.699.500;E01.370.600.115.100.160.120.699.500;G07.100.100.160.120.699.500
00000000|MMI|28.14|Daily|C0332173|[tmco]|["/day"-tx-24-"day"-noun-0,"/day"-tx-20-"day"-adj-0,"/day"-tx-12-"day"-noun-0,"/d"-tx-8-"D"-noun-0]|TX|[2280/3],[2311/3],[2367/3],[2492/3];1702/3;1219/3;916/1|
00000000|MMI|26.52|Fever|C0015967|[fndg]|["FEVER"-tx-18-"fever"-noun-0,"Febrile"-tx-16-"febrile"-adj-0]|TX|1623/5;1447/7|C23.888.119.344
00000000|MMI|26.27|Anthropological Culture|C0010453|[idcn]|["Cultures"-tx-17-"cultures"-noun-0,"Cultures"-tx-16-"cultures"-noun-0]|TX|1540/8;1466/8|I01.076.201.450;I01.880.853.100
00000000|MMI|26.26|Needs|C0027552|[qlco]|["Need"-tx-30-"need"-verb-0,"Needed"-tx-21-"needed"-adj-0]|TX|3123/4;2018/6|N03.349.380.420;N05.300.450
00000000|MMI|23.31|day|C0439228|[tmco]|["DAY"-tx-24-"day"-noun-0,"DAY"-tx-20-"day"-adj-0,"DAY"-tx-12-"day"-noun-0]|TX|[2280/3],[2311/3],[2367/3],[2492/3];1702/3;1219/3|
00000000|MMI|23.31|per day|C0439505|[tmco]|["/day"-tx-24-"day"-noun-0,"/day"-tx-20-"day"-adj-0,"/day"-tx-12-"day"-noun-0]|TX|[2280/3],[2311/3],[2367/3],[2492/3];1702/3;1219/3|
00000000|MMI|22.61|diagnosis aspect|C1704338|[qlco]|["diagnosis"-tx-2-"DIAGNOSIS"-noun-0]|TX|281/9|x.x.x.x.x.x.x
00000000|MMI|22.51|Levofloxacin|C0282386|[antb,orch]|["LEVOFLOXACIN"-tx-15-"levofloxacin"-noun-0]|TX|1392/12|D03.438.810.835.322.500.500
00000000|MMI|22.35|therapeutic aspects|C0039798|[ftcn]|["treatment"-tx-24-"treatment"-noun-0]|TX|2511/9|x.x.x.x.x.x.x
00000000|MMI|20.95|Atenolol|C0004147|[orch,phsu]|["ATENOLOL"-tx-9-"Atenolol"-noun-0]|TX|980/8|D02.033.100.624.698.070;D02.033.755.624.698.070;D02.092.063.624.698.070
00000000|MMI|20.95|Complete Blood Count|C0009555|[lbpr]|["CBC"-tx-14-"CBC"-noun-0]|TX|1303/3|E01.370.225.500.195.107;E01.370.225.625.107;E05.200.500.195.107;E05.200.625.107;E05.242.195.107;G04.170.107;G09.188.105
00000000|MMI|20.95|Endometrial Carcinoma|C0476089|[neop]|["ENDOMETRIAL CANCER"-tx-1-"Endometrial cancer"-noun-0]|TX|249/18|C04.588.945.418.948.585;C13.351.500.852.762.200;C13.351.937.418.875.200
00000000|MMI|20.95|Hypercholesterolemia|C0020443|[dsyn]|["HYPERCHOLESTEROLEMIA"-tx-2-"hypercholesterolemia"-noun-0]|TX|335/20|C18.452.584.500.500.396
00000000|MMI|19.34|Temperature|C0039476|[qnco]|["*Temperature"-tx-12-"temperature"-noun-0]|TX|1243/11|G01.906.595;G16.500.275.063.725.710;G16.500.750.775.710;N06.230.150.450;N06.230.300.100.725.710
00000000|MMI|19.20|Rhode Island|C0035487|[geoa]|["RI"-tx-32-"Ri"-noun-0]|TX|3258/2|Z01.107.567.875.550.680
00000000|MMI|17.80|Coronary Arteriosclerosis|C0010054|[dsyn]|["coronary artery disease"-tx-2-"coronary artery disease"-noun-0]|TX|309/23|C14.280.647.250.260;C14.907.137.126.339;C14.907.585.250.260
00000000|MMI|17.80|Lisinopril|C0065374|[aapp,phsu]|["Lysinopril"-tx-9-"lisinopril"-noun-0]|TX|991/10|D12.644.456.345.600
00000000|MMI|17.80|Sleep Apnea Syndromes|C0037315|[dsyn]|["Sleep apnoea"-tx-7-"sleep apnea"-noun-0]|TX|879/11|C08.618.085.852;C10.886.425.800.750
00000000|MMI|17.80|Urinalysis|C0042014|[lbpr]|["UA"-tx-14-"UA"-noun-0]|TX|1350/2|E01.370.225.124.810;E01.370.390.810;E05.200.124.810
00000000|MMI|16.30|Diabetes Mellitus, Non-Insulin-Dependent|C0011860|[dsyn]|["Type II Diabetes"-tx-7-"type 2 diabetes"-noun-0]|TX|842/15|C18.452.394.750.149;C19.246.300
00000000|MMI|16.30|Echocardiography|C0013516|[diap]|["ECHOCARDIOGRAM"-tx-6-"echocardiogram"-noun-0]|TX|732/14|E01.370.350.130.750;E01.370.350.850.220;E01.370.370.380.220
00000000|MMI|16.18|Body Temperature|C0005903|[orga]|["temperature"-tx-12-"temperature"-noun-0]|TX|1243/11|E01.370.600.875.374;G07.110
00000000|MMI|16.18|Drug Control|C0013168|[gora]|["control Medications"-tx-20-"control medications"-noun-0]|TX|1852/7,1875/11|I01.880.604.605.250;N03.706.615.402.250;N04.452.706.310
00000000|MMI|16.11|Atypical Endometrial Hyperplasia|C0349579|[dsyn]|["Atypical Endometrial Hyperplasia"-tx-1-"ATYPICAL ENDOMETRIAL HYPERPLASIA"-noun-0]|TX|65/32|C13.351.500.852.228
00000000|MMI|16.05|Adenocarcinoma|C0001418|[neop]|["ADENOCARCINOMA"-tx-3-"adenocarcinoma"-noun-0]|TX|473/14|C04.557.470.200.025
00000000|MMI|16.05|Dominican Republic|C0013014|[geoa]|["DR"-tx-25-"Dr"-noun-0]|TX|2641/2|Z01.107.084.900.300;Z01.639.880.300
00000000|MMI|15.43|To|C1883351|[qlco]|["To"-tx-30-"to"-adv-0,"To"-tx-28-"to"-adv-0,"To"-tx-20-"to"-adv-0]|TX|[3128/2],[3143/2];2871/2;1729/2|
00000000|MMI|15.17|milligram/day|C0439422|[qnco]|["mg day"-tx-24-"mg day"-noun-0]|TX|[2328/2,2339/3],[2383/2,2394/3],[2412/2,2423/3],[2557/2,2569/3]|
00000000|MMI|14.64|Diabetes Mellitus|C0011849|[dsyn]|["Diabetes"-tx-2-"diabetes"-noun-0]|TX|362/8|C18.452.394.750;C19.246
00000000|MMI|14.64|Ukraine|C0041580|[geoa]|["UA"-tx-14-"UA"-noun-0]|TX|1350/2|Z01.542.248.960;Z01.586.200.960;Z01.586.950.960
00000000|MMI|14.64|Urination|C0042034|[orgf]|["Voiding"-tx-20-"voiding"-verb-0]|TX|1804/7|G08.852.796.877
00000000|MMI|13.71|Patients|C0030705|[podg]|["*^patient"-tx-27-"patient's"-noun-0,"*^patient"-tx-11-"patient"-noun-0]|TX|2713/9;1107/7|M01.643
00000000|MMI|13.14|Blood group antigen D|C0073187|[aapp,imft]|["D NOS"-tx-8-"D"-noun-0]|TX|916/1|x.x.x.x
00000000|MMI|13.14|Injection Route of Drug Administration|C1828121|[ftcn]|["Injections"-tx-30-"injections"-noun-0]|TX|3167/10|E02.319.267.530
00000000|MMI|13.05|Constipation|C0009806|[sosy]|["CONSTIPATION"-tx-24-"constipation"-noun-0]|TX|2242/12|C23.888.821.150
00000000|MMI|13.03|Pain management|C0002766|[topp]|["Pain Control"-tx-20-"pain control"-noun-0]|TX|1847/12|E02.745;N04.590.607.500
00000000|MMI|13.02|Dental Occlusion|C0011382|[ortf]|["Occlusion"-tx-5-"occlusion"-noun-0]|TX|696/9|E06.276;G10.549.235.202
00000000|MMI|13.02|Growth|C0018270|[orgf]|["GROWTH"-tx-17-"growth"-noun-0]|TX|1526/6|G07.700.320.249
00000000|MMI|12.91|Urinary tract infection|C0042029|[dsyn]|["UTI"-tx-14-"UTI"-noun-0]|TX|1367/3|C01.539.895;C12.777.892;C13.351.968.892
00000000|MMI|12.91|urinastatin|C0077906|[aapp,phsu]|["UTI"-tx-14-"UTI"-noun-0]|TX|1367/3|x.x.x.x
00000000|MMI|12.90|Physicians|C0031831|[prog]|["DR"-tx-25-"Dr"-noun-0]|TX|2641/2|M01.526.485.810;N02.360.810
00000000|MMI|12.89|Caucasoid Race|C0007457|[popg]|["WHITE"-tx-14-"white"-adj-0]|TX|1314/5|M01.686.508.400
00000000|MMI|12.12|Show|C1547282|[anim]|["Show"-tx-14-"showed"-verb-0,"Show"-tx-6-"showed"-verb-0,"Show"-tx-5-"showing"-verb-0]|TX|1307/6;747/6;683/7|
00000000|MMI|11.49|Austria|C0004348|[geoa]|["AU"-tx-32-"Au"-noun-0]|TX|3252/2|Z01.542.088
00000000|MMI|11.49|Hypertensive disease|C0020538|[dsyn]|["HYPERTENSION"-tx-7-"hypertension"-noun-0]|TX|860/12|C14.907.489
00000000|MMI|10.93|Pain NOS Adverse Event|C1962977|[fndg]|["Pain NOS"-tx-24-"pain"-noun-0,"Pain NOS"-tx-23-"pain"-noun-0,"Pain NOS"-tx-20-"pain"-noun-0]|TX|2202/4;2162/4;1847/4|
00000000|MMI|10.72|Additional|C1524062|[ftcn]|["Additional"-tx-27-"ADDITIONAL"-adj-0,"Additional"-tx-18-"additional"-adj-0,"Additional"-tx-2-"ADDITIONAL"-adj-0]|TX|2684/10;1599/10;270/10|
00000000|MMI|10.69|20%|C3842589|[fndg]|["20%"-tx-32-"20"-fraction-0,"20%"-tx-24-"20"-integer-0]|TX|[3357/2],[3368/2];2325/2|
00000000|MMI|10.59|Event Seriousness - Significant|C1546944|[qlco]|["Significant"-tx-21-"significant"-adj-0,"Significant"-tx-7-"significant"-adj-0,"Significant"-tx-5-"Significant"-adj-0]|TX|1943/11;814/11;593/11|
00000000|MMI|10.59|Significant|C0750502|[idcn]|["Significant"-tx-21-"significant"-adj-0,"Significant"-tx-7-"significant"-adj-0,"Significant"-tx-5-"Significant"-adj-0]|TX|1943/11;814/11;593/11|
00000000|MMI|10.59|Statistical Significance|C0237881|[qnco]|["significant"-tx-21-"significant"-adj-0,"significant"-tx-7-"significant"-adj-0,"significant"-tx-5-"Significant"-adj-0]|TX|1943/11;814/11;593/11|
00000000|MMI|10.42|Medical History|C0262926|[fndg]|["Past Medical History"-tx-7-"past medical history"-noun-0,"Past Medical History"-tx-5-"PAST MEDICAL HISTORY"-noun-0]|TX|790/20;571/20|
00000000|MMI|10.42|PMH - past medical history|C0455458|[fndg]|["Past medical history"-tx-7-"past medical history"-noun-0,"Past medical history"-tx-5-"PAST MEDICAL HISTORY"-noun-0]|TX|790/20;571/20|
00000000|MMI|10.06|Drug Allergy|C0013182|[dsyn]|["Drug Allergies"-tx-10-"drug allergies"-noun-1]|TX|1069/14|C20.543.206;C25.100.468
00000000|MMI|9.88|Disease Management|C0376636|[hlca]|["management"-tx-4-"management"-noun-0]|TX|558/10|N04.590.607
00000000|MMI|9.85|Female|C0015780|[orga]|["FEMALE"-tx-3-"female"-noun-0]|TX|429/6|x.x.x
00000000|MMI|9.85|Females|C0086287|[popg]|["female"-tx-3-"female"-noun-0]|TX|429/6|x.x.x
00000000|MMI|9.81|Rehabilitation aspects|C0034992|[ftcn]|["Rehabilitation"-tx-21-"Rehabilitation"-noun-0]|TX|1889/14|x.x.x
00000000|MMI|9.76|Tablet Dosage Form|C0039225|[bodm]|["TAB"-tx-24-"tab"-noun-0]|TX|2446/3|D26.255.830
00000000|MMI|9.75|Hemorrhage|C0019080|[patf]|["Blood loss"-tx-11-"blood loss"-noun-0]|TX|1179/10|C23.550.414
00000000|MMI|8.57|steri-strip|C0727944|[medd]|["steri-strip"-tx-29-"Steri-Strip"-noun-0,"steri-strip"-tx-28-"Steri-Strips"-noun-0]|TX|2896/11;2827/12|
00000000|MMI|8.34|Gases|C0017110|[chvs]|["Gas"-tx-20-"gas"-noun-0]|TX|1836/3|D01.362
00000000|MMI|8.34|Hypersensitivity|C0020517|[patf]|["Allergies"-tx-10-"ALLERGIES"-noun-0]|TX|1049/9|C20.543
00000000|MMI|7.70|Closure by staple|C0185012|[topp]|["Staples"-tx-29-"staples"-noun-0,"Staples"-tx-27-"staples"-noun-0]|TX|2965/7;2723/7|
00000000|MMI|7.62|Clinical Study Follow-up|C3274571|[hlca]|["FOLLOW-UP"-tx-25-"FOLLOWUP"-noun-0,"FOLLOW-UP"-tx-25-"follow up"-adj-0]|TX|2607/8;2626/9|
00000000|MMI|7.62|Follow-Up Report|C1704685|[inpr]|["Follow-Up"-tx-25-"FOLLOWUP"-noun-0,"Follow-Up"-tx-25-"follow up"-adj-0]|TX|2607/8;2626/9|
00000000|MMI|7.62|Follow-up status|C0589120|[fndg]|["Follow-up"-tx-25-"FOLLOWUP"-noun-0,"Follow-up"-tx-25-"follow up"-adj-0]|TX|2607/8;2626/9|
00000000|MMI|7.62|follow-up|C1522577|[hlca]|["Follow Up"-tx-25-"follow up"-adj-0,"Followup"-tx-25-"FOLLOWUP"-noun-0]|TX|2626/9;2607/8|
00000000|MMI|7.53|Send (transmission)|C1519246|[ftcn]|["Sent"-tx-28-"sent"-verb-0,"Sent"-tx-16-"sent"-verb-0]|TX|2848/4;1480/4|
00000000|MMI|7.47|Removed|C0849355|[qlco]|["Removed"-tx-29-"removed"-verb-0,"Removed"-tx-27-"removed"-verb-0]|TX|2977/7;2741/7|
00000000|MMI|7.40|Home environment|C0442519|[cnce]|["HOME"-tx-30-"home"-adj-0,"HOME"-tx-21-"home"-noun-0]|TX|3181/4;2070/4|
00000000|MMI|7.36|Abortion consent:Finding:Point in time:^Patient:Document|C2360836|[clna]|["Patient"-tx-27-"patient's"-noun-0,"Patient"-tx-11-"patient"-noun-0]|TX|2713/9;1107/7|
00000000|MMI|7.36|Hysterectomy consent:Finding:Point in time:^Patient:Document|C2360838|[clna]|["Patient"-tx-27-"patient's"-noun-0,"Patient"-tx-11-"patient"-noun-0]|TX|2713/9;1107/7|
00000000|MMI|7.36|Sterilization consent:Finding:Point in time:^Patient:Document|C2360840|[clna]|["Patient"-tx-27-"patient's"-noun-0,"Patient"-tx-11-"patient"-noun-0]|TX|2713/9;1107/7|
00000000|MMI|7.33|Attending (action)|C1999232|[ftcn]|["attending"-tx-32-"Attending"-noun-0,"attending"-tx-1-"ATTENDING"-noun-0]|TX|3305/9;189/9|
00000000|MMI|7.33|Attending (provider role)|C1547429|[prog]|["Attending"-tx-32-"Attending"-noun-0,"Attending"-tx-1-"ATTENDING"-noun-0]|TX|3305/9;189/9|
00000000|MMI|7.31|Apyrexial|C0277797|[fndg]|["Afebrile"-tx-20-"afebrile"-adj-0,"Afebrile"-tx-19-"afebrile"-adj-0]|TX|1689/8;1665/8|
00000000|MMI|7.28|Singular|C0205171|[qnco]|["Singular"-tx-24-"Singular"-adj-0,"Alone"-tx-21-"alone"-adj-0]|TX|2400/8;2091/5|
00000000|MMI|7.23|Patient need for (contextual qualifier)|C0686904|[ftcn]|["need"-tx-30-"need"-verb-0,"needed"-tx-21-"needed"-adj-0]|TX|3123/4;2018/6|
00000000|MMI|7.22|Medications:-:Point in time:^Patient:-|C2598133|[clna]|["Medications"-tx-20-"medications"-noun-0,"Medications"-tx-9-"MEDICATIONS"-noun-0]|TX|1875/11;954/11|
00000000|MMI|7.22|Medications:Presence or Identity:Duration of the study:^Patient:Nominal|C0802604|[clna]|["Medications"-tx-20-"medications"-noun-0,"Medications"-tx-9-"MEDICATIONS"-noun-0]|TX|1875/11;954/11|
00000000|MMI|7.22|Pharmaceutical Preparations|C0013227|[phsu]|["Medications"-tx-20-"medications"-noun-0,"Medications"-tx-9-"MEDICATIONS"-noun-0]|TX|1875/11;954/11|D26
00000000|MMI|7.15|Dosage|C0178602|[qnco]|["Doses"-tx-24-"doses"-noun-0]|TX|[2501/5],[2579/5]|
00000000|MMI|7.11|3+ Answer to Question|C3838680|[fndg]|["3+"-tx-32-"3"-fraction-0]|TX|[3355/1],[3366/1]|
00000000|MMI|7.11|3+ Score|C2827736|[qnco]|["3+"-tx-32-"3"-fraction-0]|TX|[3355/1],[3366/1]|
00000000|MMI|7.11|3+ Score, WHO|C2981702|[clas]|["3+"-tx-32-"3"-fraction-0]|TX|[3355/1],[3366/1]|
00000000|MMI|7.11|<3 (qualifier value)|C0439086|[qnco]|["<3"-tx-32-"3"-fraction-0]|TX|[3355/1],[3366/1]|
00000000|MMI|7.10|100%|C3817553|[qnco]|["100%"-tx-18-"100"-real_number-0,"100%"-tx-5-"100"-percentage-0]|TX|1565/3;691/3|
00000000|MMI|7.09|dvt prophylaxis|C0853245|[topp]|["dvt prophylaxis"-tx-30-"DVT prophylaxis"-noun-0,"dvt prophylaxis"-tx-24-"DVT prophylaxis"-noun-0]|TX|3037/15;2589/15|
00000000|MMI|7.04|Registered nurse|C0687673|[prog]|["R.N."-tx-24-"r.n"-adj-0,"R.N."-tx-23-"r.n"-adj-0]|TX|2197/3;2157/3|
00000000|MMI|6.97|P Blood group antibodies|C0369773|[aapp,imft]|["P NOS"-tx-24-"p"-adj-0,"P NOS"-tx-23-"p"-adj-0]|TX|2195/1;2155/1|
00000000|MMI|6.97|P prime|C2603361|[clna]|["P'"-tx-24-"p"-adj-0,"P'"-tx-23-"p"-adj-0]|TX|2195/1;2155/1|
00000000|MMI|6.97|Signature|C1519316|[inpr]|["Signed"-tx-1-"Signed"-noun-0]|TX|[100/6],[156/6]|
00000000|MMI|6.97|signed - ParticipationSignature|C1561610|[inpr]|["signed"-tx-1-"Signed"-noun-0]|TX|[100/6],[156/6]|
00000000|MMI|6.95|10%|C3842590|[fndg]|["10%"-tx-24-"10"-integer-0]|TX|[2380/2],[2409/2]|
00000000|MMI|6.70|Woman|C0043210|[popg]|["female"-tx-3-"female"-noun-0]|TX|429/6|M01.975
00000000|MMI|5.18|% live|C1634625|[qlco]|["% live"-tx-21-"lives"-verb-0]|TX|2085/5|
00000000|MMI|5.18|Admission activity|C0809949|[hlca]|["Admitted"-tx-11-"admitted"-verb-0]|TX|1119/8|
00000000|MMI|5.18|Arranged (transportation)|C1546854|[idcn]|["Arranged"-tx-30-"arranged"-verb-0]|TX|3134/8|
00000000|MMI|5.18|Diabetes|C0011847|[dsyn]|["Diabetes"-tx-2-"diabetes"-noun-0]|TX|362/8|
00000000|MMI|5.18|Endometrial intraepithelial neoplasia|C1333394|[neop]|["Endometrial Intraepithelial Neoplasia"-tx-3-"endometrial intraepithelial neoplasia"-noun-0]|TX|491/37|
00000000|MMI|5.18|Fever symptoms (finding)|C0424755|[fndg]|["Fever"-tx-18-"fever"-noun-0]|TX|1623/5|
00000000|MMI|5.18|H/O: surgery|C0455610|[fndg]|["Past surgical history"-tx-8-"PAST SURGICAL HISTORY"-noun-0]|TX|893/21|
00000000|MMI|5.18|History of present illness|C0262512|[orga]|["HISTORY OF PRESENT ILLNESS"-tx-3-"HISTORY OF PRESENT ILLNESS"-noun-0]|TX|373/26|
00000000|MMI|5.18|History of present illness:Finding:Point in time:^Patient:Nominal:Reported|C0488508|[clna]|["History of present illness"-tx-3-"HISTORY OF PRESENT ILLNESS"-noun-0]|TX|373/26|
00000000|MMI|5.18|Hospital admission|C0184666|[hlca]|["admitted"-tx-11-"admitted"-verb-0]|TX|1119/8|
00000000|MMI|5.18|Hospital course|C0489547|[fndg]|["Hospital course"-tx-11-"HOSPITAL COURSE"-noun-0]|TX|1086/15|
00000000|MMI|5.18|Hospital course:Finding:Point in time:^Patient:Narrative|C0488549|[clna]|["Hospital course"-tx-11-"HOSPITAL COURSE"-noun-0]|TX|1086/15|
00000000|MMI|5.18|Household composition|C0595998|[fndg]|["lives"-tx-21-"lives"-verb-0]|TX|2085/5|
00000000|MMI|5.18|Hypercholesterolemia result|C1522133|[fndg]|["Hypercholesterolemia"-tx-2-"hypercholesterolemia"-noun-0]|TX|335/20|
00000000|MMI|5.18|Hypertension Adverse Event|C1963138|[fndg]|["Hypertension"-tx-7-"hypertension"-noun-0]|TX|860/12|
00000000|MMI|5.18|Live - Specimen Condition|C1548795|[qlco]|["Live"-tx-21-"lives"-verb-0]|TX|2085/5|
00000000|MMI|5.18|Living Alone|C0439044|[fndg]|["Alone"-tx-21-"alone"-adj-0]|TX|2091/5|
00000000|MMI|5.18|Malignant neoplasm of endometrium|C0007103|[neop]|["Endometrial cancer"-tx-1-"Endometrial cancer"-noun-0]|TX|249/18|
00000000|MMI|5.18|Medical Examination|C0582103|[hlca]|["Exam"-tx-13-"Exam"-noun-0]|TX|1281/4|
00000000|MMI|5.18|Medication.discharge|C0806915|[fndg]|["Discharge medications"-tx-22-"DISCHARGE MEDICATIONS"-noun-0]|TX|2099/21|
00000000|MMI|5.18|Nuclear cap binding complex location|C2263086|[celc]|["CBC"-tx-14-"CBC"-noun-0]|TX|1303/3|
00000000|MMI|5.18|Obtain|C1301820|[ftcn]|["Obtained"-tx-21-"obtained"-verb-0]|TX|1918/8|
00000000|MMI|5.18|On admission|C0457453|[tmco]|["On admission"-tx-9-"ON ADMISSION"-adj-0]|TX|966/12|
00000000|MMI|5.18|PAGR1 wt Allele|C3812826|[gngm]|["GAS"-tx-20-"gas"-noun-0]|TX|1836/3|
00000000|MMI|5.18|Reside|C2982691|[acty]|["Live"-tx-21-"lives"-verb-0]|TX|2085/5|
00000000|MMI|5.18|SLEEP APNEA (device)|C3496180|[medd]|["SLEEP APNEA"-tx-7-"sleep apnea"-noun-0]|TX|879/11|
00000000|MMI|5.18|Singulair|C0595724|[orch,phsu]|["Singulair"-tx-9-"Singulair"-noun-0]|TX|1023/9|
00000000|MMI|5.18|Stable Disease|C0677946|[fndg]|["Stable condition"-tx-20-"stable condition"-noun-0]|TX|1765/16|
00000000|MMI|5.18|Stable chronic Graft vs Host Disease|C3538874|[fndg]|["Stable condition"-tx-20-"stable condition"-noun-0]|TX|1765/16|
00000000|MMI|5.18|Tmax|C2348796|[qnco]|["TMAX"-tx-18-"T-max"-noun-0]|TX|1555/5|
00000000|MMI|5.18|Uterine Corpus Cancer|C1883486|[neop]|["Endometrial Cancer"-tx-1-"Endometrial cancer"-noun-0]|TX|249/18|
00000000|MMI|5.18|alone - group size|C0679994|[grpa]|["alone"-tx-21-"alone"-adj-0]|TX|2091/5|
00000000|MMI|5.18|gastrointestinal gas|C0596601|[sosy]|["Gas"-tx-20-"gas"-noun-0]|TX|1836/3|
00000000|MMI|3.98|Pass (indicator)|C2828386|[fndg]|["Pass"-tx-20-"passing"-verb-0]|TX|1828/7|
00000000|MMI|3.98|Place|C0442504|[spco]|["Place"-tx-29-"placed"-verb-0]|TX|2918/6|
00000000|MMI|3.98|Place - dosing instruction imperative|C1704765|[ftcn]|["Place"-tx-29-"placed"-verb-0]|TX|2918/6|
00000000|MMI|3.98|Return to (contextual qualifier) (qualifier value)|C0332156|[qlco]|["Return"-tx-21-"returning"-verb-0]|TX|2060/9|
00000000|MMI|3.98|put - instruction imperative|C1882509|[acty]|["Place"-tx-29-"placed"-verb-0]|TX|2918/6|
00000000|MMI|3.78|P & S|C0722388|[orch,phsu]|["P & S"-tx-20-"p."-noun-0]|TX|1795/1,1796/1|
00000000|MMI|3.78|Subglottic pressure|C0234833|[ortf]|["P s"-tx-20-"p."-noun-0]|TX|1795/1,1796/1|
00000000|MMI|3.75|1 Day|C1442449|[tmco]|["Day 1"-tx-16-"day 1"-noun-0]|TX|1424/3,1429/1|
00000000|MMI|3.75|Day 2|C3842676|[fndg]|["Day 2"-tx-17-"day 2"-noun-0]|TX|1504/3,1509/1|
00000000|MMI|3.75|Day 3|C3842675|[fndg]|["Day 3"-tx-19-"day 3"-noun-0]|TX|1648/3,1653/1|
00000000|MMI|3.75|Discharge date|C2361123|[tmco]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|163/14|
00000000|MMI|3.75|Discharge date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2361122|[clna]|["Discharge date"-tx-1-"Discharge Date"-noun-0]|TX|163/14|
00000000|MMI|3.72|Diabetic on diet only|C0421246|[topp]|["Diet controlled Diabetes"-tx-7-"diet-controlled diabetes"-noun-0]|TX|826/15,849/8|
00000000|MMI|3.72|Suggestive of|C0332299|[ftcn]|["Suggestive of"-tx-14-"suggestive of"-adj-0]|TX|1353/13|
00000000|MMI|3.71|One day|C3844320|[fndg]|["One day"-tx-24-"one day"-noun-0]|TX|2442/3,2458/3|
00000000|MMI|3.68|At|C1516077|[spco]|["At"-tx-30-"at"-adj-0]|TX|3178/2|
00000000|MMI|3.68|Bands|C0175723|[medd]|["Bands"-tx-14-"bands"-noun-0]|TX|1342/5|
00000000|MMI|3.68|Clinical act of insertion|C0441587|[hlca]|["Placement"-tx-21-"placement"-noun-0]|TX|1904/9|
00000000|MMI|3.68|Diagnosis|C0011900|[fndg]|["DIAGNOSIS"-tx-2-"DIAGNOSIS"-noun-0]|TX|281/9|E01
00000000|MMI|3.68|Diagnosis Study|C1704656|[resa]|["DIAGNOSIS"-tx-2-"DIAGNOSIS"-noun-0]|TX|281/9|
00000000|MMI|3.68|Doctor of Medicine|C1512018|[inpr]|["M.D."-tx-31-"M.D"-noun-0]|TX|3247/3|
00000000|MMI|3.68|Document type|C1547673|[inpr]|["Document"-tx-31-"document"-noun-0]|TX|3199/8|
00000000|MMI|3.68|Documents|C1301746|[inpr]|["document"-tx-31-"document"-noun-0]|TX|3199/8|
00000000|MMI|3.68|Echocardiogram (image)|C2243117|[inpr]|["Echocardiogram"-tx-6-"echocardiogram"-noun-0]|TX|732/14|
00000000|MMI|3.68|GATM wt Allele|C4049625|[gngm]|["AT"-tx-30-"at"-adj-0]|TX|3178/2|
00000000|MMI|3.68|Injection of therapeutic agent|C0021485|[topp]|["injections"-tx-30-"injections"-noun-0]|TX|3167/10|
00000000|MMI|3.68|Injection procedure|C1533685|[topp]|["INJECTIONS"-tx-30-"injections"-noun-0]|TX|3167/10|
00000000|MMI|3.68|Instruction [Publication Type]|C0302828|[inpr]|["instructions"-tx-27-"INSTRUCTIONS"-noun-0]|TX|2695/12|
00000000|MMI|3.68|Instructions|C1442085|[idcn]|["Instructions"-tx-27-"INSTRUCTIONS"-noun-0]|TX|2695/12|
00000000|MMI|3.68|Instructions:Text:Point in time:^Patient:Narrative|C3263700|[clna]|["Instructions"-tx-27-"INSTRUCTIONS"-noun-0]|TX|2695/12|
00000000|MMI|3.68|Placement|C1524072|[qlco]|["Placement"-tx-21-"placement"-noun-0]|TX|1904/9|
00000000|MMI|3.68|Placement action|C1533810|[hlca]|["Placement"-tx-21-"placement"-noun-0]|TX|1904/9|
00000000|MMI|3.68|Staple Device Component|C3887591|[mnob]|["Staple"-tx-28-"staple"-noun-0]|TX|2808/6|
00000000|MMI|3.65|Admitting diagnosis|C0332133|[fndg]|["Admitting diagnosis"-tx-1-"ADMITTING DIAGNOSIS"-noun-0]|TX|228/19|
00000000|MMI|3.65|Report status|C0586177|[fndg]|["Report status"-tx-1-"Report Status"-noun-0]|TX|141/13|
00000000|MMI|3.64|Rehab facility|C4035867|[hcro,mnob]|["Rehab facility"-tx-30-"rehab facility"-noun-0]|TX|3097/14|
00000000|MMI|3.63|0%|C3842591|[fndg]|["0%"-tx-12-"0"-integer-0]|TX|1223/1|
00000000|MMI|3.63|M NOS ANTIBODY|C0369637|[aapp,imft]|["M NOS"-tx-12-"m"-noun-0]|TX|1199/1|
00000000|MMI|3.63|M+ (tumor staging)|C0441923|[inpr]|["M+"-tx-12-"m"-noun-0]|TX|1199/1|
00000000|MMI|3.63|Repeat|C0205341|[ftcn]|["Repeat"-tx-12-"repeat"-noun-0]|TX|1266/6|
00000000|MMI|3.63|Repeat Object|C1705914|[cnce]|["Repeat"-tx-12-"repeat"-noun-0]|TX|1266/6|
00000000|MMI|3.63|Repeat Pattern|C1547730|[tmco]|["Repeat"-tx-12-"repeat"-noun-0]|TX|1266/6|
00000000|MMI|3.63|Type 2|C0441730|[clas]|["Type 2"-tx-7-"type 2"-noun-0]|TX|842/6|
00000000|MMI|3.62|Admission date:Time Stamp -- Date and Time:Point in time:^Patient:Quantitative|C2598112|[clna]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|115/14|
00000000|MMI|3.62|Date of admission|C1302393|[tmco]|["Admission date"-tx-1-"Admission Date"-noun-0]|TX|115/14|
00000000|MMI|3.62|Physiotherapy service|C0587629|[topp]|["Physical therapy service"-tx-21-"physical therapy services"-noun-0]|TX|2025/25|
00000000|MMI|3.61|Friday|C0585029|[tmco]|["Friday"-tx-27-"Friday"-noun-0]|TX|2789/6|
00000000|MMI|3.61|Day 7|C3842672|[fndg]|["Day 7"-tx-27-"day 7"-noun-0]|TX|2766/3,2771/1|
00000000|MMI|3.61|Fraction of|C1264633|[qnco]|["Fraction of"-tx-6-"fraction of"-noun-0]|TX|766/11|
00000000|MMI|3.60|C-Circle|C3538933|[celc]|["CC"-tx-31-"CC"-noun-0]|TX|3230/2|
00000000|MMI|3.60|week|C0439230|[tmco]|["WEEKS"-tx-26-"weeks"-noun-0]|TX|2660/5|
00000000|MMI|3.59|6 Hours|C1292428|[tmco]|["6H"-tx-23-"6h"-noun-0]|TX|2190/2|
00000000|MMI|3.59|23|C0450348|[qnco]|["23"-tx-1-"23"-fraction-0]|TX|43/2|
00000000|MMI|3.59|3 Hours|C1442460|[tmco]|["3H"-tx-22-"3h"-noun-0]|TX|2150/2|
00000000|MMI|3.59|Pyrexia of unknown origin (excl puerperal)|C0856281|[sosy]|["puo"-tx-1-"PUO"-noun-0]|TX|12/3|
00000000|MMI|3.59|24 Hours|C1442770|[tmco]|["24 Hours"-tx-18-"24 hours"-noun-0]|TX|1610/8|
00000000|MMI|3.59|24 hour time frame|C0439584|[tmco]|["24 hours"-tx-18-"24 hours"-noun-0]|TX|1610/8|
00000000|MMI|3.59|Continuous|C0549178|[idcn]|["Continue"-tx-30-"continue"-verb-0]|TX|3013/8|
00000000|MMI|3.59|Started|C1272689|[qlco]|["Started"-tx-15-"started"-verb-0]|TX|1381/7|
00000000|MMI|3.59|per 24 hours|C0456696|[tmco]|["/24 hours"-tx-18-"24 hours"-noun-0]|TX|1610/8|
00000000|MMI|3.59|Constipation Adverse Event|C1963087|[fndg]|["Constipation"-tx-24-"constipation"-noun-0]|TX|2242/12|
00000000|MMI|3.57|Administration occupational activities|C0001554|[ocac]|["Management"-tx-4-"management"-noun-0]|TX|558/10|
00000000|MMI|3.57|Focal|C0205234|[spco]|["Focus"-tx-3-"focus"-noun-0]|TX|464/5|
00000000|MMI|3.57|Has focus|C1285542|[ftcn]|["focus"-tx-3-"focus"-noun-0]|TX|464/5|
00000000|MMI|3.57|Management Occupations|C3273539|[ocdi]|["Management"-tx-4-"management"-noun-0]|TX|558/10|
00000000|MMI|3.57|Management procedure|C1273870|[ocac]|["Management"-tx-4-"management"-noun-0]|TX|558/10|
00000000|MMI|3.57|October|C3828732|[qlco]|["October"-tx-5-"October"-noun-0]|TX|670/7|
00000000|MMI|3.57|Operative|C1882154|[tmco]|["Operative"-tx-4-"operative"-adj-0]|TX|548/9|
00000000|MMI|3.57|Pain control|C1304888|[topp]|["Pain control"-tx-20-"pain control"-noun-0]|TX|1847/12|
00000000|MMI|3.57|Performed|C0884358|[ftcn]|["Performed"-tx-5-"performed"-verb-0]|TX|657/9|
00000000|MMI|3.57|Perpendicular|C3272860|[cnce]|["Perpendicular"-tx-29-"perpendicular"-adj-0]|TX|2925/13|
00000000|MMI|3.57|Perpendicular axis|C1295725|[spco]|["Perpendicular"-tx-29-"perpendicular"-adj-0]|TX|2925/13|
00000000|MMI|3.57|Present|C0150312|[qnco]|["Present"-tx-4-"presents"-verb-0]|TX|535/8|
00000000|MMI|3.57|Presentation|C0449450|[idcn]|["Present"-tx-4-"presents"-verb-0]|TX|535/8|
00000000|MMI|3.56|Cardiovascular occlusion|C1110554|[patf]|["OCCLUSION"-tx-5-"occlusion"-noun-0]|TX|696/9|
00000000|MMI|3.56|Count|C0750480|[qnco]|["Count"-tx-14-"count"-noun-0]|TX|1320/5|
00000000|MMI|3.56|Count Dosing Unit|C1705566|[qnco]|["COUNT"-tx-14-"count"-noun-0]|TX|1320/5|
00000000|MMI|3.56|Ejection as a Circumstance of Injury|C0302131|[phpr]|["Ejection"-tx-6-"ejection"-noun-0]|TX|757/8|
00000000|MMI|3.56|Ejection as a Sports activity|C0336969|[dora]|["Ejection"-tx-6-"ejection"-noun-0]|TX|757/8|
00000000|MMI|3.56|Ejection time|C0812388|[orga]|["ejection"-tx-6-"ejection"-noun-0]|TX|757/8|
00000000|MMI|3.56|Growth action|C2911660|[acty]|["Growth"-tx-17-"growth"-noun-0]|TX|1526/6|
00000000|MMI|3.56|Obstruction|C0028778|[patf]|["Occlusion"-tx-5-"occlusion"-noun-0]|TX|696/9|
00000000|MMI|3.56|Occluded|C1947917|[ftcn]|["Occlusion"-tx-5-"occlusion"-noun-0]|TX|696/9|
00000000|MMI|3.56|Occlusion - action|C0441597|[ftcn]|["Occlusion"-tx-5-"occlusion"-noun-0]|TX|696/9|
00000000|MMI|3.56|Occlusion within Medical Device|C1882137|[phpr]|["Occlusion"-tx-5-"occlusion"-noun-0]|TX|696/9|
00000000|MMI|3.56|Tissue Growth|C1621966|[ortf]|["Growth"-tx-17-"growth"-noun-0]|TX|1526/6|
00000000|MMI|3.56|growth aspects|C0220844|[phsf]|["growth"-tx-17-"growth"-noun-1]|TX|1526/6|
00000000|MMI|3.55|Observed|C1441672|[ftcn]|["Observed"-tx-18-"observed"-verb-0]|TX|1583/8|
00000000|MMI|3.55|dictated - DocumentCompletion|C1609990|[idcn]|["Dictated"-tx-32-"Dictated"-noun-0]|TX|3275/8|
00000000|MMI|3.55|dictated - ParticipationMode|C1548384|[ftcn]|["dictated"-tx-32-"Dictated"-noun-0]|TX|3275/8|
00000000|MMI|3.55|Total abdominal hysterectomy with bilateral salpingo-oophorectomy|C0542407|[topp]|["tah bso"-tx-11-"TAHBSO"-noun-0]|TX|1159/6|
00000000|MMI|3.54|Female Phenotype|C1705498|[qlco]|["Female"-tx-3-"female"-noun-0]|TX|429/6|
00000000|MMI|3.54|Female, Self-Report|C1705497|[qlco]|["Female"-tx-3-"female"-noun-0]|TX|429/6|
00000000|MMI|3.51|Ambulate|C4036205|[fndg]|["Ambulate"-tx-21-"ambulating"-noun-0]|TX|1966/10|
00000000|MMI|3.50|Concurrent|C0205420|[tmco]|["Concurrent"-tx-6-"concurrent"-adj-0]|TX|721/10|
00000000|MMI|3.50|Rehabilitation - specialty|C1306847|[bmod]|["Rehabilitation"-tx-21-"Rehabilitation"-noun-0]|TX|1889/14|
00000000|MMI|3.49|Aspirin 81 MG|C0983882|[clnd]|["Aspirin 81 MG"-tx-24-"aspirin 81 mg"-noun-0]|TX|2345/13|
00000000|MMI|3.49|Atenolol 50 MG|C0983889|[clnd]|["Atenolol 50 MG"-tx-24-"atenolol 50 mg"-noun-0]|TX|2257/14|
00000000|MMI|3.49|Levofloxacin 500 MG|C0992502|[clnd]|["Levofloxacin 500 MG"-tx-24-"levofloxacin 500 mg"-noun-0]|TX|2464/19|
00000000|MMI|3.49|Lisinopril 30 MG|C0987220|[clnd]|["Lisinopril 30 MG"-tx-24-"lisinopril 30 mg"-noun-0]|TX|2286/16|
00000000|MMI|3.48|Percocet Tablets|C0307251|[clnd]|["Percocet Tablets"-tx-22-"Percocet tablets"-noun-0]|TX|2122/8,2135/7|
00000000|MMI|3.48|Ibuprofen 800 MG|C0986668|[clnd]|["Ibuprofen 800 MG"-tx-23-"Motrin 800 mg"-noun-0]|TX|2169/13|
00000000|MMI|3.48|Known|C0205309|[qlco]|["Known"-tx-10-"known"-adj-0]|TX|1063/5|
00000000|MMI|3.48|diet controlled|C0743195|[topp]|["diet controlled"-tx-7-"diet-controlled"-adj-0]|TX|826/15|
00000000|MMI|3.47|+2|C0740116|[qnco]|["+2"-tx-1-"2"-fraction-0]|TX|179/1|
00000000|MMI|3.47|2+|C3833492|[fndg]|["2+"-tx-1-"2"-fraction-0]|TX|179/1|
00000000|MMI|3.47|2+ Score|C2827735|[qnco]|["2+"-tx-1-"2"-fraction-0]|TX|179/1|
00000000|MMI|3.47|2+ Score, WHO|C2981700|[clas]|["2+"-tx-1-"2"-fraction-0]|TX|179/1|
00000000|MMI|3.47|CLINT1 gene|C1824745|[gngm]|["CLINT"-tx-31-"Clint"-noun-0]|TX|3234/5|
00000000|MMI|3.46|+5|C0728893|[qnco]|["+5"-tx-1-"5"-fraction-0]|TX|131/1|
00000000|MMI|3.46|>5|C0439084|[qnco]|[">5"-tx-1-"5"-fraction-0]|TX|131/1|
00000000|MMI|3.46|ETS Variant Gene 6 Protein|C0254343|[aapp,bacs]|["TEL"-tx-31-"Tel"-noun-0]|TX|3226/3|
00000000|MMI|3.46|ETV6 gene|C0796520|[gngm]|["TEL"-tx-31-"Tel"-noun-0]|TX|3226/3|
00000000|MMI|3.46|Identifier|C0600091|[inpr]|["ID"-tx-32-"ID"-noun-0]|TX|3341/2|
00000000|MMI|3.46|Immune diffusion|C1441613|[lbpr]|["ID"-tx-32-"ID"-noun-0]|TX|3341/2|
00000000|MMI|3.46|Telecommunication Address Data Type|C3272379|[inpr]|["TEL"-tx-31-"Tel"-noun-0]|TX|3226/3|
00000000|MMI|3.46|/40|C0439509|[tmco]|["/40"-tx-24-"40"-integer-0]|TX|2554/2|
00000000|MMI|3.46|40%|C3842587|[qnco]|["40%"-tx-24-"40"-integer-0]|TX|2554/2|
00000000|MMI|3.45|Diagnostic interview schedule|C0451119|[inpr]|["DIS"-tx-1-"DIS"-noun-0]|TX|109/3|
00000000|MMI|3.45|Discontinued|C1444662|[fndg]|["DIS"-tx-1-"DIS"-noun-0]|TX|109/3|
00000000|MMI|3.45|Multivitamin preparation|C0301532|[orch,phsu,vita]|["Multivitamin"-tx-24-"multivitamin"-noun-0]|TX|2429/12|
00000000|MMI|3.45|Tablet Dosing Unit|C1705223|[qnco]|["Tab"-tx-24-"tab"-noun-0]|TX|2446/3|
00000000|MMI|3.45|Docusate Sodium 100 MG|C3153447|[clnd]|["Docusate Sodium 100 MG"-tx-24-"Colace 100 mg"-noun-0]|TX|2209/13|
00000000|MMI|3.45|AMBP gene|C1412376|[gngm]|["UTI"-tx-14-"UTI"-noun-0]|TX|1367/3|
00000000|MMI|3.45|Before|C0332152|[tmco]|["Prior to"-tx-21-"prior to"-prep-0]|TX|2051/8|
00000000|MMI|3.45|Day 4|C3840892|[fndg]|["Day 4"-tx-20-"day 4"-noun-0]|TX|1755/3,1760/1|
00000000|MMI|3.44|Actual blood loss|C0553700|[clna]|["Blood loss"-tx-11-"blood loss"-noun-0]|TX|1179/10|
00000000|MMI|3.44|Blood Loss|C3163616|[fndg]|["Blood Loss"-tx-11-"blood loss"-noun-0]|TX|1179/10|
00000000|MMI|3.44|Postoperative fever|C0424786|[patf]|["Postoperative fever"-tx-24-"postoperative fever"-noun-0]|TX|2524/19|
00000000|MMI|3.44|Fever treatment|C0150234|[topp]|["treatment fever"-tx-24-"treatment fever"-noun-0]|TX|2511/9,2538/5|
00000000|MMI|3.44|Cranial incision point|C2338258|[blor]|["Incision"-tx-29-"incision"-noun-0]|TX|2946/8|
00000000|MMI|3.44|Delayed Release Dosage Form|C1707664|[bodm]|["DR"-tx-25-"Dr"-noun-0]|TX|2641/2|
00000000|MMI|3.44|Device to Subject Relationship Domain|C3540849|[inpr]|["DR"-tx-25-"Dr"-noun-0]|TX|2641/2|
00000000|MMI|3.44|Doctor - Title|C2348314|[cnce]|["Dr."-tx-25-"Dr"-noun-0]|TX|2641/2|
00000000|MMI|3.44|Surgical incisions|C0184898|[topp]|["Incision"-tx-29-"incision"-noun-0]|TX|2946/8|
00000000|MMI|3.44|Surgical wound|C0332803|[inpo]|["Incision"-tx-29-"incision"-noun-0]|TX|2946/8|
00000000|MMI|3.43|70%|C3842584|[fndg]|["70%"-tx-6-"70"-percentage-0]|TX|778/2|
00000000|MMI|3.43|Caucasians|C0043157|[popg]|["WHITE"-tx-14-"white"-adj-0]|TX|1314/5|
00000000|MMI|3.43|January|C3829466|[qlco]|["January"-tx-30-"January"-noun-0]|TX|3059/7|
00000000|MMI|3.43|White color|C0220938|[qlco]|["WHITE"-tx-14-"white"-adj-0]|TX|1314/5|
00000000|MMI|3.43|RNH1 gene|C1826843|[gngm]|["RI"-tx-32-"Ri"-noun-0]|TX|3258/2|
00000000|MMI|3.42|Administration procedure|C1533734|[topp]|["Treatment"-tx-24-"treatment"-noun-0]|TX|2511/9|
00000000|MMI|3.42|Biomaterial Treatment|C1705169|[cnce]|["Treatment"-tx-24-"treatment"-noun-0]|TX|2511/9|
00000000|MMI|3.42|Drop measurement|C1321095|[qnco]|["X4"-tx-24-"x4"-noun-0]|TX|2498/2|
00000000|MMI|3.42|Mild (qualifier value)|C2945599|[qlco]|["Minimal"-tx-11-"minimal"-adj-0]|TX|1171/7|
00000000|MMI|3.42|Minimal|C0547040|[qlco]|["Minimal"-tx-11-"minimal"-adj-0]|TX|1171/7|
00000000|MMI|3.42|Minimum|C1524031|[qlco]|["MINIMAL"-tx-11-"minimal"-adj-0]|TX|1171/7|
00000000|MMI|3.42|Therapeutic procedure|C0087111|[topp]|["Treatment"-tx-24-"treatment"-noun-0]|TX|2511/9|E02
00000000|MMI|3.42|Treating|C1522326|[ftcn]|["Treatment"-tx-24-"treatment"-noun-0]|TX|2511/9|
00000000|MMI|3.42|Treatment Epoch|C3538994|[resa]|["TREATMENT"-tx-24-"treatment"-noun-0]|TX|2511/9|
00000000|MMI|3.42|Uncomplicated|C0443334|[qlco]|["Uncomplicated"-tx-11-"uncomplicated"-adj-0]|TX|1145/13|
00000000|MMI|3.42|X4|C3854162|[fndg]|["X4"-tx-24-"x4"-noun-0]|TX|2498/2|
00000000|MMI|3.42|treatment - ActInformationManagementReason|C3887704|[hlca]|["treatment"-tx-24-"treatment"-